Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Lululemon (LULU) PT, Estimate Cut at Canaccord Genuity Amid 'Wearhouse Sale'
-
Orsu Metals Corporation: Lapse of Mandate With UniCredit and Barclays
-
Canaccord Genuity Starts Inotek Pharmaceuticals (ITEK) at Buy
-
Veresen Announces Common Share Dividend for March 2015
-
Abaxis (ABAX) PT Lifted to $72 at Canaccord Genuity
-
Canaccord Genuity Starts Perceptron (PRCP) at Buy
-
Buy Spectranetics (SPNC) on Weakness, Canaccord Genuity Says
-
Air Canada Partners With The Next Billion: Women & The Economy Of The Future Conference
-
Vericel to Present at Canaccord Genuity and ARM Investor Conferences
-
Vericel to Present at Canaccord Genuity and ARM Investor Conferences
-
Tekmira Pharma (TKMR) Appoints Three New Executives
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
HubSpot (HUBS) 4.1M Offering Prices at $37/Share
-
HubSpot Announces Pricing of Follow-on Offering
-
Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 24
-
ISTO Technologies to Present at the 2015 Canaccord Genuity Musculoskeletal Conference on March 24, 2015
-
Silver Wheaton Announces Closing of US$800 Million Bought-Deal Common Share Financing
-
Black Diamond (BDE) PT Raised Sharply at Canaccord Genuity on Potential Sale; Sees 140% Upside
-
Gastar Exploration Limited (GST) PT Trimmed to $4 at Canaccord Genuity
-
Silver Wheaon (SLW) Closes 38.9M Common Offering at $20.55/Share
-
Silver Wheaton announces closing of US$800 million bought-deal common share financing
-
Aquinox Pharmaceutical (AQXP) PT Lifted to $17 at Canaccord Genuity
-
Histogenics Corporation to Present at the 2015 Canaccord Genuity Musculoskeletal Conference
-
Oncolytics Biotech® Inc. Announces 2014 Year End Results
-
Aquinox Pharmaceuticals Announces Year End 2014 Financial Results
-
Aquinox Pharmaceuticals Announces Year End 2014 Financial Results
-
Canaccord Genuity Starts Intersect ENT (XENT) at Buy
-
AxoGen, Inc. to Present at Canaccord Genuity's Musculoskeletal Conference
-
Unique Resources Corp. Announces A Letter of Intent to Acquire Bee Vectoring Technology Inc. and Engagement of Canaccord Genuity Corp. to Complete A Concurrent Financing
-
Notable Analyst Rating Changes 3/13: (EBAY) (INTC) (MBLY) Upgraded; (HST) (QIWI) (LL) Downgraded
-
UPDATE: Canaccord Genuity Downgrades Broadcom (BRCM) to Hold
-
UPDATE: Canaccord Genuity Upgrades Intel (INTC) to Buy on Data Center, IoT Strength
-
Canaccord Genuity Upgrades Rockwell Collins (COL) to Buy
-
Veresen Reports 2014 Fourth Quarter and Year-End Results, Affirms 2015 Guidance and Announces New Independent Director Nominee
-
CONMED Corporation to Present at the 2015 Canaccord Genuity Musculoskeletal Conference
-
GC-Global Capital Corp. Announces Closing of Best Efforts Public Offering
-
Aduro Biotech (ADRO) Files $86.25M IPO
-
Chesswood Group Limited Announces Closing of $32 Million Public Offering and Concurrent $6 Million Private Placement
-
Greencastle Renews Normal Course Issuer Bid and Cancels 1,792,000 Shares
-
Kaminak Announces Closing of $21 Million Bought Deal Private Placement
-
Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants
-
Canaccord Genuity Positive on DSW (DSW) Into Q4 Print
-
Benefitfocus (BNFT) Price Target Lifted to $45 at Canaccord Genuity Following Analyst Day
-
Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference
-
Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference
-
SolarEdge Technologies (SEDG) Commences 7M Common IPO
-
SolarEdge Technologies, Inc. Announces the Lanuch of its Initial Public Offering
-
Alphatec Spine to Present at 10th Annual Canaccord Genuity Musculoskeletal Conference
-
Alphatec Spine to Present at 10th Annual Canaccord Genuity Musculoskeletal Conference


